Assurance of quality, safety and efficacy of vaccines through compliance of quality management processes

M. Taj, S. Adeel, M. W. Malik, Amina Najam, K. Batool
{"title":"Assurance of quality, safety and efficacy of vaccines through compliance of quality management processes","authors":"M. Taj, S. Adeel, M. W. Malik, Amina Najam, K. Batool","doi":"10.15406/japlr.2019.08.00337","DOIUrl":null,"url":null,"abstract":"Immunization is one of the most rewarding effective and economical health interventions known to mankind to-date. Since last 50 years successful vaccination campaigns has resulted in extermination of small pox, dropped global polio incidence by 99% and had efficaciously reduced the disability, illness and morbidity caused by the vaccine preventable diseases. Immunization is a crucial constituent behind the efforts taken to meet millennium development goals reducing the mortality in children under-five by over 50 percent, decreasing from 90 to 43 deaths per 1,000 live births between 1990 and 2015.1 To ensure continuous positive results from immunization WHO has stressed upon the need of stringent quality assurance measures which is dependent upon control / monitoring of raw materials; adequacy of production processes, suitability quality control methods and specifications, and control / monitoring of final finished products. The present paper assesses all the essential tools required for the development of a quality biological product. These factors safeguard the safety, efficacy, integrity and quality of vaccines; a result of adequate quality management system which is based upon quality risk management approach (validations, consistency of production, vendor qualifications, independent lot release etc). Efficacy of vaccines","PeriodicalId":92063,"journal":{"name":"Journal of analytical & pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of analytical & pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/japlr.2019.08.00337","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Immunization is one of the most rewarding effective and economical health interventions known to mankind to-date. Since last 50 years successful vaccination campaigns has resulted in extermination of small pox, dropped global polio incidence by 99% and had efficaciously reduced the disability, illness and morbidity caused by the vaccine preventable diseases. Immunization is a crucial constituent behind the efforts taken to meet millennium development goals reducing the mortality in children under-five by over 50 percent, decreasing from 90 to 43 deaths per 1,000 live births between 1990 and 2015.1 To ensure continuous positive results from immunization WHO has stressed upon the need of stringent quality assurance measures which is dependent upon control / monitoring of raw materials; adequacy of production processes, suitability quality control methods and specifications, and control / monitoring of final finished products. The present paper assesses all the essential tools required for the development of a quality biological product. These factors safeguard the safety, efficacy, integrity and quality of vaccines; a result of adequate quality management system which is based upon quality risk management approach (validations, consistency of production, vendor qualifications, independent lot release etc). Efficacy of vaccines
通过遵守质量管理程序保证疫苗的质量、安全性和有效性
免疫接种是迄今为止人类已知的最有效和最经济的卫生干预措施之一。50年来,成功的疫苗接种运动消灭了天花,使全球脊髓灰质炎发病率下降了99%,并有效地减少了由疫苗可预防疾病引起的残疾、疾病和发病率。免疫接种是为实现千年发展目标所作努力的关键组成部分,这些目标将五岁以下儿童死亡率降低50%以上,在1990年至2015年期间将每千名活产婴儿的死亡人数从90人减少到43人。为确保免疫接种取得持续的积极成果,世卫组织强调需要采取严格的质量保证措施,这取决于对原材料的控制/监测;生产过程的充分性,质量控制方法和规范的适用性,以及最终成品的控制/监控。本文评估了开发高质量生物制品所需的所有基本工具。这些因素保障了疫苗的安全性、有效性、完整性和质量;基于质量风险管理方法的充分质量管理体系的结果(验证、生产一致性、供应商资格、独立批号放行等)。疫苗的功效
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书